ArticleArchives of gynecology and obstetrics2022

Patterns of use and outcomes of adjuvant bevacizumab therapy prior to regulatory approval in women with newly diagnosed ovarian cancer.

Charlotte R Gamble et al.PubMed ↗Publisher ↗

No numbers read from the abstract.